NEW YORK (Reuters Health) – Prostate specific antigen (PSA) doubling time as measured before radical prostatectomy does not predict biochemical progression after surgery, according to a report in…
NEW YORK (Reuters Health) – Urinary dipstick and microscopy testing are not good at finding urinary tract infection when pain is not one of the symptoms, UK researchers…
NEW YORK (Reuters Health) – Polymerase chain reaction (PCR) analysis of dried blood spots is an insensitive means of neonatal screening for cytomegalovirus (CMV) infection, a large study…
NEW YORK (Reuters Health) – Solid organ recipients often develop invasive fungal infections months or even years after transplant, according to registry data from the U.S. Depending on…
NEW YORK (Reuters Health) – Breast cancer patients with ATM missense variants who receive radiation therapy appear to be at increased risk for contralateral breast cancer, according to…
NEW YORK (Reuters Health) – Ultrasound surveillance is a safe alternative to immediate resection for small testicular masses discovered incidentally, Canadian researchers report. Small testicular masses are occasionally…
NEW YORK (Reuters Health) – Gene expression-based signatures for lung cancer don’t seem any better than currently used prognostic factors at identifying patients who need adjuvant chemotherapy, researchers…
NEW YORK (Reuters Health) – Excisional biopsies are best for diagnosing cutaneous melanoma, because partial biopsies have higher risks of misdiagnosis, adverse events, and microstaging inaccuracy, Australian researchers…
NEW YORK (Reuters Health) – As first-line treatment for progressive chronic lymphocytic leukemia (CLL), cladribine and fludarabine are equally effective and safe in combination with cyclophosphamide, according to…
NEW YORK (Reuters Health) – A new biomarker – tumor-associated CD68+ macrophages — predicts poor outcomes in patients with classic Hodgkin’s lymphoma, new research indicates. About 20% of…
